Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

I knew it was bound to happen at some point, but this soon – if you’re thinking in context, 10 years is not that far off. So, ...

The US Food and Drug Administration (FDA) has granted approval to Roche's VENTANA MET (SP44) RxDx Assay to help determine the ...

First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in ...

As the FDA prepares for a busy Oncologic Drugs Advisory Committee next week, an agency insider told BioSpace that volunteers ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous ...

France's Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...